TP53 and cervical squamous intraepithelial neoplasia: In the CIN subgroup, 71% of tumors harbor TP53 mutations [3], which are mainly missense and occur in the region encoding the DNA-binding domain, leading to the abrogation of p53 degradation mediated by MDM2 binding.